Tilray Inc - Ordinary Shares - Class 2
NASDAQ:TLRY
| Market Cap (Intraday) | 3.31B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $15.12 |
| 50-Day MA | $9.39 |
| 200-Day MA | $7.70 |
Tilray, Inc. Stock, NASDAQ:TLRY
1920 EASTLAKE AVENUE E., SEATTLE, WA 98102
United States of America
Phone: 2064329325
Number of Employees: 688
Description
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical research applications. It operates in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, Israel, Ireland, New Zealand, South Africa, Switzerland, the United States, and the United Kingdom. The company was incorporated in 2018 and is headquartered in Nanaimo, Canada.